Meghan Heberton

Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis to Dermal Hypersensitivity Reaction

Paul V. Viscuse, Mario L. Marques‐Piubelli, Meghan Heberton et al. · Frontiers in Oncology · 2021 · 47 citations · Full text

Pathology, Immune Profiling, Dermatology +17

A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes

Delfina Bur, Anisha B. Patel, Kelly A. Nelson et al. · Journal of the American Academy of Dermatology · 2022 · 23 citations

Management Outcomes, Immunology, Immunotherapy-induced Bullous Pemphigoid +2

Severe de novo pustular psoriasiform immune‐related adverse event associated with nivolumab treatment for metastatic esophageal adenocarcinoma

Riyad N. H. Seervai, Meghan Heberton, Woo Cheal Cho et al. · Journal of Cutaneous Pathology · 2021 · 11 citations

Esophageal Cancer, Nivolumab Treatment, Immunology +19

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment

Taylor C. Duke, Ranjit Nair, Carlos A. Torres‐Cabala et al. · JAAD Case Reports · 2020 · 10 citations · Full text

Paraneoplastic pemphigus manifesting in a patient treated with pembrolizumab for urothelial carcinoma

Michelle A. McNally, Ramya Vangipuram, Matthew T. Campbell et al. · JAAD Case Reports · 2021 · 10 citations · Full text